Tian Wang

No. 8 Caobao Road
Xuhui, 200233, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Primary Chemoradiotherapy Versus Primary Surgery for Non-Metastatic Sinonasal Rhabdomyosarcoma in Adolescents and Adults.

Primary Chemoradiotherapy Versus Primary Surgery for Non-Metastatic Sinonasal Rhabdomyosarcoma in Adolescents and Adults.

Journal: Head & neck

Published: August 04, 2025

UBE2K Facilitates Erlotinib Resistance and Induces Epithelial Mesenchymal Transition in Osteosarcoma Cancer Stem-Like Cells via Activating the mTOR Signaling.

UBE2K Facilitates Erlotinib Resistance and Induces Epithelial Mesenchymal Transition in Osteosarcoma Cancer Stem-Like Cells via Activating the mTOR Signaling.

Journal: Pharmacology

Published: September 12, 2024

Multimodality Treatment Outcome in Adult Patients with Head and Neck Rhabdomyosarcoma.

Multimodality Treatment Outcome in Adult Patients with Head and Neck Rhabdomyosarcoma.

Journal: The Laryngoscope

Published: June 20, 2024

Synthesis of two Fluorescent Complexes and Their use as Multifunctional Nanomedicine Carriers for Rhabdomyosarcoma Treatment.

Synthesis of two Fluorescent Complexes and Their use as Multifunctional Nanomedicine Carriers for Rhabdomyosarcoma Treatment.

Journal: Journal of fluorescence

Published: May 06, 2024

Incidence and patterns of lymph node metastases in head and neck rhabdomyosarcoma: One-institution study.

Incidence and patterns of lymph node metastases in head and neck rhabdomyosarcoma: One-institution study.

Journal: Head & neck

Published: March 19, 2024

Surgery for adult head and neck rhabdomyosarcoma: A retrospective report from one institution.

Surgery for adult head and neck rhabdomyosarcoma: A retrospective report from one institution.

Journal: International forum of allergy & rhinology

Published: October 18, 2023

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy.

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy.

Journal: Cancer management and research

Published: June 19, 2022

Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma.

Doxorubicin and Edelfosine Combo-Loaded Lipid-Polymer Hybrid Nanoparticles for Synergistic Anticancer Effect Against Drug-Resistant Osteosarcoma.

Journal: OncoTargets and therapy

Published: April 30, 2020

Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1.

Visfatin is involved in the cisplatin resistance of osteosarcoma cells via upregulation of Snail and Zeb1.

Journal: Cancer biology & therapy

Published: April 13, 2019

The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.

The TGFβ-miR-499a-SHKBP1 pathway induces resistance to EGFR inhibitors in osteosarcoma cancer stem cell-like cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: February 14, 2019

Showing 1-10 of 10

Last Updated: 09/26/2026